Journal of Clinical Biochemistry and Nutrition
Online ISSN : 1880-5086
Print ISSN : 0912-0009
ISSN-L : 0912-0009
Original Articles
Crosstalk between NOD2 and TLR2 suppresses the development of TLR2-mediated experimental colitis
Natsuki OkaiYasuhiro MasutaYasuo OtsukaAkane HaraSho MasakiKen KamataKosuke MinagaHajime HonjoMasatoshi KudoTomohiro Watanabe
Author information
Keywords: NOD2, TLR2, ATG16L1, colitis
JOURNAL OPEN ACCESS

2024 Volume 74 Issue 2 Pages 146-153

Details
Abstract

Nucleotide-binding oligomerization domain 2 (NOD2) is an intra­cellular sensor for muramyl dipeptide (MDP), a degradation product of bacterial cell wall peptidoglycan (PGN). PGN stimulates cell-surface Toll-like receptor 2 (TLR2) independently of NOD2, indicating the presence of crosstalk between extracellular TLR2 and intracellular NOD2 upon exposure to PGN. NOD2-deficient mice were sensitive, while TLR2-deficient mice were resistant to experimental colitis induced by intrarectal administration of PGN. Severe colitis in NOD2-deficient mice was accompanied by increased expression of nuclear factor-kappa B-dependent cyto­kines and decreased expression of autophagy-related 16-like 1 (ATG16L1). MDP activation of NOD2 enhanced autophagy mediated by TLR2 in human dendritic cells. mRNA expression of TLR2 tended to be higher in the colonic mucosa of patients with active ulcerative colitis compared to that of those in remission. Induction of remission was associated with increased mRNA expression of ATG16L1 in both ulcerative colitis and Crohn’s disease patients. Conversely, mRNA expression of receptor-interacting serine/threonine-protein kinase 2 was higher in the inflammatory colonic mucosa of patients with active disease than in the non-inflamed mucosa of patients in remission, in both ulcerative colitis and Crohn’s disease. These findings highlight the role of NOD2-TLR2 crosstalk in the immunopathogenesis of colitis.

Content from these authors
© 2024 JCBN

This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License.
https://creativecommons.org/licenses/by-nc-nd/4.0/
Previous article Next article
feedback
Top